Harmony Biosciences Holdings, Inc. Detailed Financials

Full historical quarterly statements

Metric2026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-30
Total Revenue215.4M243.8M239.5M200.5M184.7M201.3M186.0M172.8M
Cost of Goods Sold44.5M68.5M59.6M38.2M32.0M54.4M42.8M32.1M
Gross Profit170.9M175.2M179.8M162.3M152.7M146.9M143.3M140.7M
R&D Expenses69.4M49.9M55.0M50.2M34.5M34.7M25.4M63.6M
Operating Expenses133.6M136.7M114.3M114.2M96.5M91.1M81.5M119.3M
Operating Income37.3M38.6M65.5M48.2M56.2M55.7M61.7M21.4M
Other Income / Gains2.4M2.2M2.0M1.5M932K428K460K338K
Net Income32.5M22.5M50.9M39.8M45.6M49.5M46.1M11.6M
EPS (Diluted)0.560.390.880.690.800.870.810.20
Reported CurrencyUSDUSDUSDUSDUSDUSDUSDUSD
Gross Profit Ratio0.7930.7190.7510.810.8270.730.770.814
General And Administrative Expenses32.5M57.6M29.8M33.9M31.2M28.9M28.6M27.2M
Selling And Marketing Expenses31.7M29.2M29.5M30.1M30.7M27.6M27.6M28.5M
Selling General And Administrative Expenses64.2M86.7M59.4M64.0M62.0M56.5M56.2M55.7M
Other Expenses00000000
Cost And Expenses178.1M205.2M174.0M152.3M128.5M145.5M124.3M151.5M
Interest Income5.8M5.9M5.7M5.3M5.0M4.5M4.9M4.7M
Interest Expense3.2M3.5M3.6M3.6M3.8M4.2M4.3M4.4M
Depreciation And Amortization6.0M7.4M6.0M6.0M6.0M6.0M6.0M6.1M
Ebitda48.9M51.7M73.5M59.3M67.0M66.3M72.5M32.1M
Ebitdaratio0.2270.2120.3070.2960.3630.330.390.186
Operating Income Ratio0.1730.1580.2730.240.3040.2770.3320.124
Income Before Tax39.7M40.8M67.5M49.6M57.2M56.2M62.2M21.7M
Income Before Tax Ratio0.1840.1670.2820.2480.310.2790.3340.126
Income Tax Expense7.2M18.3M16.6M9.9M11.6M6.7M16.1M10.1M
Net Income Ratio0.1510.0920.2120.1980.2470.2460.2480.067
Epsdiluted0.550.380.870.680.780.850.790.20
Weighted Average Shs Out57.8M57.6M58.5M57.5M57.3M57.1M56.9M56.8M
Weighted Average Shs Out Dil58.8M58.7M58.7M58.4M58.5M58.2M58.1M57.5M